Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 9.49738757 |
2 | * sarcomere organization (GO:0045214) | 9.20276410 |
3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.23242203 |
4 | myofibril assembly (GO:0030239) | 8.21121469 |
5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.57084902 |
6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.10162572 |
7 | cardiac muscle cell development (GO:0055013) | 6.95012664 |
8 | * cardiac muscle contraction (GO:0060048) | 6.82055220 |
9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.54744246 |
10 | cardiac cell development (GO:0055006) | 6.53361927 |
11 | adult heart development (GO:0007512) | 6.47590978 |
12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.47520320 |
13 | tricarboxylic acid cycle (GO:0006099) | 6.39640894 |
14 | * muscle filament sliding (GO:0030049) | 6.36881314 |
15 | * actin-myosin filament sliding (GO:0033275) | 6.36881314 |
16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.26003760 |
17 | ventricular cardiac muscle cell action potential (GO:0086005) | 6.18799659 |
18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.16927576 |
19 | cardiac muscle hypertrophy (GO:0003300) | 6.14545727 |
20 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.10391649 |
21 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.01835173 |
22 | regulation of relaxation of muscle (GO:1901077) | 6.00351593 |
23 | * actomyosin structure organization (GO:0031032) | 5.80641885 |
24 | regulation of sarcomere organization (GO:0060297) | 5.79848379 |
25 | striated muscle hypertrophy (GO:0014897) | 5.79817828 |
26 | plasma membrane repair (GO:0001778) | 5.79430436 |
27 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.75645198 |
28 | heart trabecula formation (GO:0060347) | 5.60587070 |
29 | detection of calcium ion (GO:0005513) | 5.54658365 |
30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.41542593 |
31 | * muscle tissue morphogenesis (GO:0060415) | 5.39336909 |
32 | regulation of the force of heart contraction (GO:0002026) | 5.38904068 |
33 | * regulation of actin filament-based movement (GO:1903115) | 5.26498727 |
34 | * actin-mediated cell contraction (GO:0070252) | 5.26446141 |
35 | heart contraction (GO:0060047) | 5.23227736 |
36 | heart process (GO:0003015) | 5.23227736 |
37 | cardiac ventricle formation (GO:0003211) | 5.15506955 |
38 | cell communication involved in cardiac conduction (GO:0086065) | 5.15102356 |
39 | muscle hypertrophy (GO:0014896) | 5.14941021 |
40 | * striated muscle contraction (GO:0006941) | 5.04357768 |
41 | regulation of skeletal muscle contraction (GO:0014819) | 5.02371307 |
42 | carnitine shuttle (GO:0006853) | 5.00378781 |
43 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.00010910 |
44 | * regulation of striated muscle contraction (GO:0006942) | 4.87907345 |
45 | regulation of membrane repolarization (GO:0060306) | 4.87562119 |
46 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.85464607 |
47 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.76045128 |
48 | cellular response to epinephrine stimulus (GO:0071872) | 4.72488255 |
49 | regulation of cell communication by electrical coupling (GO:0010649) | 4.68002693 |
50 | cell communication by electrical coupling (GO:0010644) | 4.66900787 |
51 | atrial septum morphogenesis (GO:0060413) | 4.59808992 |
52 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.54669525 |
53 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.54493293 |
54 | regulation of cardiac muscle contraction (GO:0055117) | 4.49504270 |
55 | response to epinephrine (GO:0071871) | 4.48975016 |
56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.43244237 |
57 | muscle hypertrophy in response to stress (GO:0003299) | 4.42240867 |
58 | cardiac muscle adaptation (GO:0014887) | 4.42240867 |
59 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.42240867 |
60 | regulation of cardioblast differentiation (GO:0051890) | 4.41309301 |
61 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.37915083 |
62 | fatty acid transmembrane transport (GO:1902001) | 4.31373223 |
63 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.30327945 |
64 | adrenergic receptor signaling pathway (GO:0071875) | 4.29932711 |
65 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.28496159 |
66 | cardiac muscle cell action potential (GO:0086001) | 4.25987020 |
67 | ventricular cardiac muscle cell development (GO:0055015) | 4.22623886 |
68 | relaxation of cardiac muscle (GO:0055119) | 4.21017611 |
69 | regulation of cofactor metabolic process (GO:0051193) | 4.16589607 |
70 | regulation of coenzyme metabolic process (GO:0051196) | 4.16589607 |
71 | negative regulation of potassium ion transport (GO:0043267) | 4.14827051 |
72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.14492306 |
73 | negative regulation of protein localization to cell surface (GO:2000009) | 4.12522935 |
74 | ATP synthesis coupled proton transport (GO:0015986) | 4.11551366 |
75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.11551366 |
76 | * regulation of heart rate (GO:0002027) | 4.09551760 |
77 | cardiac muscle tissue development (GO:0048738) | 4.03326297 |
78 | positive regulation of action potential (GO:0045760) | 4.02342503 |
79 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.98535325 |
80 | * actin filament-based movement (GO:0030048) | 3.95445508 |
81 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.93475156 |
82 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.92032461 |
83 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.88408631 |
84 | * regulation of heart contraction (GO:0008016) | 3.86972991 |
85 | response to caffeine (GO:0031000) | 3.83400002 |
86 | cardiac conduction (GO:0061337) | 3.81430884 |
87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.80580003 |
88 | NADH metabolic process (GO:0006734) | 3.77112440 |
89 | respiratory electron transport chain (GO:0022904) | 3.74713375 |
90 | oxygen transport (GO:0015671) | 3.74471048 |
91 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.74052231 |
92 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.72888248 |
93 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71861357 |
94 | * regulation of muscle contraction (GO:0006937) | 3.71635794 |
95 | striated muscle cell development (GO:0055002) | 3.71590519 |
96 | oxidative phosphorylation (GO:0006119) | 3.71298375 |
97 | * positive regulation of ATP catabolic process (GO:1903291) | 3.69206759 |
98 | * positive regulation of ATPase activity (GO:0032781) | 3.69206759 |
99 | carnitine transmembrane transport (GO:1902603) | 3.68387198 |
100 | atrioventricular valve morphogenesis (GO:0003181) | 3.67932625 |
101 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.64033526 |
102 | electron transport chain (GO:0022900) | 3.63334913 |
103 | trabecula formation (GO:0060343) | 3.62466230 |
104 | * regulation of ATP catabolic process (GO:1903289) | 3.60963162 |
105 | * regulation of ATPase activity (GO:0043462) | 3.60963162 |
106 | response to inactivity (GO:0014854) | 3.60775244 |
107 | * muscle contraction (GO:0006936) | 3.60684662 |
108 | positive regulation of heart contraction (GO:0045823) | 3.54208437 |
109 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.53624822 |
110 | striated muscle adaptation (GO:0014888) | 3.53222459 |
111 | positive regulation of heart rate (GO:0010460) | 3.52876343 |
112 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.47779386 |
113 | positive regulation of cation channel activity (GO:2001259) | 3.43863770 |
114 | regulation of sulfur metabolic process (GO:0042762) | 3.37994802 |
115 | potassium ion export (GO:0071435) | 3.37836849 |
116 | cardiac chamber formation (GO:0003207) | 3.36481379 |
117 | * muscle system process (GO:0003012) | 3.35132274 |
118 | carnitine transport (GO:0015879) | 3.34826940 |
119 | amino-acid betaine transport (GO:0015838) | 3.34826940 |
120 | outflow tract septum morphogenesis (GO:0003148) | 3.33587225 |
121 | * regulation of muscle system process (GO:0090257) | 3.33144573 |
122 | creatine metabolic process (GO:0006600) | 3.32355875 |
123 | negative regulation of myotube differentiation (GO:0010832) | 3.31967950 |
124 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.26819934 |
125 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.26819934 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.63404703 |
2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.58103051 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.46475883 |
4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.32893774 |
5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.32893774 |
6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.06368313 |
7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.61992879 |
8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.47271969 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.27461261 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.12375202 |
11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.92843443 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60137076 |
13 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.55194923 |
14 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.54058103 |
15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20811794 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07362949 |
17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06545984 |
18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95640463 |
19 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.92286725 |
20 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.90106608 |
21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.86702761 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82410100 |
23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72317884 |
24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70291661 |
25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.63696127 |
26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63660995 |
27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62985432 |
28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60626424 |
29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54794817 |
30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54774565 |
31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54269455 |
32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49563132 |
33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45757676 |
34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41287288 |
35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39916794 |
36 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.35733667 |
37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32050895 |
38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31453854 |
39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30047065 |
40 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29929022 |
41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29834056 |
42 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27543470 |
43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.27511751 |
44 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27346348 |
45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26934166 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25951070 |
47 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22141874 |
48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21533579 |
49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20640869 |
50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20457506 |
51 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18500396 |
52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17735605 |
53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16542372 |
54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15058011 |
55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13223786 |
56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12995087 |
57 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.09399324 |
58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.08790411 |
59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08313903 |
60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08313903 |
61 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06586530 |
62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06559766 |
63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06017698 |
64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05935017 |
65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05238063 |
66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04688746 |
67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03591700 |
68 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01927082 |
69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01645435 |
70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00924539 |
71 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.99855348 |
72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99392101 |
73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97452735 |
74 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97103120 |
75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96961516 |
76 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96821091 |
77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94003848 |
78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93650229 |
79 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93462062 |
80 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.93275412 |
81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92995968 |
82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92883081 |
83 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92567468 |
84 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92465235 |
85 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.91854511 |
86 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91787862 |
87 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91699711 |
88 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90932292 |
89 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90412994 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89930039 |
91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89762324 |
92 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89432622 |
93 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88887418 |
94 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88295404 |
95 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.87450870 |
96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87397985 |
97 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.87118653 |
98 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86345002 |
99 | P68_20966046_ChIP-Seq_HELA_Human | 0.85553212 |
100 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.85236940 |
101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84697471 |
102 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84149005 |
103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83823072 |
104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83479143 |
105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83395260 |
106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83100502 |
107 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82490115 |
108 | TBL1_22424771_ChIP-Seq_293T_Human | 0.82363531 |
109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81513833 |
110 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81512057 |
111 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81093063 |
112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80964144 |
113 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80941167 |
114 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.80570202 |
115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79873876 |
116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79603823 |
117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78728464 |
118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78603311 |
119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78319687 |
120 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.77741288 |
121 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.77628651 |
122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77621357 |
123 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.76773141 |
124 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76733350 |
125 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.76610998 |
126 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76393139 |
127 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76163900 |
128 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.75739557 |
129 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.74756338 |
130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.74601188 |
131 | TCF4_23295773_ChIP-Seq_U87_Human | 0.74069254 |
132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74069102 |
133 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.72432685 |
134 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.72202557 |
135 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.70838027 |
136 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70239983 |
137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69841653 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0004084_abnormal_cardiac_muscle | 6.01323084 |
2 | * MP0002837_dystrophic_cardiac_calcinosis | 5.83336014 |
3 | MP0003646_muscle_fatigue | 5.44269317 |
4 | MP0000751_myopathy | 5.13628152 |
5 | * MP0004215_abnormal_myocardial_fiber | 5.00559646 |
6 | * MP0004036_abnormal_muscle_relaxation | 4.16529644 |
7 | * MP0005330_cardiomyopathy | 4.05641675 |
8 | MP0000749_muscle_degeneration | 3.73781709 |
9 | MP0008775_abnormal_heart_ventricle | 3.45354192 |
10 | * MP0002972_abnormal_cardiac_muscle | 3.42849765 |
11 | MP0003137_abnormal_impulse_conducting | 3.27973247 |
12 | * MP0004087_abnormal_muscle_fiber | 3.09036071 |
13 | * MP0005385_cardiovascular_system_phenoty | 2.83879613 |
14 | * MP0001544_abnormal_cardiovascular_syste | 2.83879613 |
15 | * MP0010630_abnormal_cardiac_muscle | 2.83600643 |
16 | MP0006138_congestive_heart_failure | 2.80126237 |
17 | MP0000750_abnormal_muscle_regeneration | 2.71885259 |
18 | * MP0005620_abnormal_muscle_contractility | 2.69674016 |
19 | MP0003828_pulmonary_edema | 2.66025319 |
20 | MP0004484_altered_response_of | 2.54098408 |
21 | MP0004085_abnormal_heartbeat | 2.45579749 |
22 | MP0002106_abnormal_muscle_physiology | 2.41481175 |
23 | MP0004130_abnormal_muscle_cell | 2.32206020 |
24 | MP0004510_myositis | 2.26986773 |
25 | MP0002269_muscular_atrophy | 2.20083015 |
26 | MP0003221_abnormal_cardiomyocyte_apopto | 2.16143466 |
27 | MP0005369_muscle_phenotype | 1.93062257 |
28 | MP0002127_abnormal_cardiovascular_syste | 1.92808341 |
29 | MP0000759_abnormal_skeletal_muscle | 1.77492482 |
30 | MP0004145_abnormal_muscle_electrophysio | 1.74326242 |
31 | MP0003950_abnormal_plasma_membrane | 1.73439806 |
32 | MP0000747_muscle_weakness | 1.70317273 |
33 | MP0004233_abnormal_muscle_weight | 1.61887031 |
34 | MP0006036_abnormal_mitochondrial_physio | 1.59809155 |
35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.54773107 |
36 | MP0008004_abnormal_stomach_pH | 1.42425504 |
37 | MP0010368_abnormal_lymphatic_system | 1.39283350 |
38 | MP0003279_aneurysm | 1.35659588 |
39 | MP0005666_abnormal_adipose_tissue | 1.31833666 |
40 | MP0002332_abnormal_exercise_endurance | 1.31042981 |
41 | * MP0000266_abnormal_heart_morphology | 1.26068769 |
42 | MP0000343_altered_response_to | 1.23307418 |
43 | MP0005670_abnormal_white_adipose | 1.22994121 |
44 | MP0005165_increased_susceptibility_to | 1.15878210 |
45 | MP0002234_abnormal_pharynx_morphology | 1.13742500 |
46 | MP0006035_abnormal_mitochondrial_morpho | 0.98923822 |
47 | MP0005623_abnormal_meninges_morphology | 0.97459640 |
48 | MP0003566_abnormal_cell_adhesion | 0.96099916 |
49 | * MP0002128_abnormal_blood_circulation | 0.88708511 |
50 | MP0005451_abnormal_body_composition | 0.88550261 |
51 | MP0005375_adipose_tissue_phenotype | 0.86777063 |
52 | MP0000230_abnormal_systemic_arterial | 0.85882466 |
53 | MP0003705_abnormal_hypodermis_morpholog | 0.82831262 |
54 | MP0004185_abnormal_adipocyte_glucose | 0.81418572 |
55 | MP0000767_abnormal_smooth_muscle | 0.80024317 |
56 | MP0004272_abnormal_basement_membrane | 0.79825920 |
57 | MP0005266_abnormal_metabolism | 0.78140986 |
58 | MP0001879_abnormal_lymphatic_vessel | 0.75190140 |
59 | MP0002108_abnormal_muscle_morphology | 0.69362673 |
60 | MP0001661_extended_life_span | 0.66038612 |
61 | MP0008438_abnormal_cutaneous_collagen | 0.64999407 |
62 | MP0002909_abnormal_adrenal_gland | 0.63200161 |
63 | MP0003806_abnormal_nucleotide_metabolis | 0.59011904 |
64 | MP0002925_abnormal_cardiovascular_devel | 0.58414598 |
65 | MP0005187_abnormal_penis_morphology | 0.55907653 |
66 | MP0005503_abnormal_tendon_morphology | 0.54907356 |
67 | MP0003984_embryonic_growth_retardation | 0.54350858 |
68 | MP0002088_abnormal_embryonic_growth/wei | 0.53351842 |
69 | MP0000003_abnormal_adipose_tissue | 0.49681841 |
70 | MP0009384_cardiac_valve_regurgitation | 0.49236089 |
71 | MP0005319_abnormal_enzyme/_coenzyme | 0.45982916 |
72 | MP0004043_abnormal_pH_regulation | 0.45786196 |
73 | MP0001614_abnormal_blood_vessel | 0.45659929 |
74 | MP0001784_abnormal_fluid_regulation | 0.45634499 |
75 | MP0000733_abnormal_muscle_development | 0.44886305 |
76 | MP0001984_abnormal_olfaction | 0.43802277 |
77 | MP0005275_abnormal_skin_tensile | 0.43484344 |
78 | MP0000013_abnormal_adipose_tissue | 0.41968482 |
79 | MP0002254_reproductive_system_inflammat | 0.40714140 |
80 | MP0002078_abnormal_glucose_homeostasis | 0.39975232 |
81 | MP0004147_increased_porphyrin_level | 0.37003733 |
82 | MP0005409_darkened_coat_color | 0.34871798 |
83 | MP0002971_abnormal_brown_adipose | 0.34489280 |
84 | MP0005595_abnormal_vascular_smooth | 0.33965381 |
85 | MP0008961_abnormal_basal_metabolism | 0.33826150 |
86 | MP0008569_lethality_at_weaning | 0.33166652 |
87 | MP0001958_emphysema | 0.33149467 |
88 | MP0003948_abnormal_gas_homeostasis | 0.32588859 |
89 | MP0006072_abnormal_retinal_apoptosis | 0.32204020 |
90 | MP0001672_abnormal_embryogenesis/_devel | 0.31144094 |
91 | MP0005380_embryogenesis_phenotype | 0.31144094 |
92 | MP0002090_abnormal_vision | 0.29888288 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.29622021 |
94 | MP0008874_decreased_physiological_sensi | 0.28312381 |
95 | MP0005386_behavior/neurological_phenoty | 0.27878870 |
96 | MP0004924_abnormal_behavior | 0.27878870 |
97 | MP0005388_respiratory_system_phenotype | 0.27481750 |
98 | MP0002133_abnormal_respiratory_system | 0.27481750 |
99 | MP0005535_abnormal_body_temperature | 0.27211893 |
100 | MP0001727_abnormal_embryo_implantation | 0.26119426 |
101 | MP0002295_abnormal_pulmonary_circulatio | 0.25994053 |
102 | MP0000249_abnormal_blood_vessel | 0.24673509 |
103 | MP0009115_abnormal_fat_cell | 0.23442357 |
104 | MP0009840_abnormal_foam_cell | 0.22424708 |
105 | MP0003878_abnormal_ear_physiology | 0.22296420 |
106 | MP0005377_hearing/vestibular/ear_phenot | 0.22296420 |
107 | MP0009763_increased_sensitivity_to | 0.20132376 |
108 | MP0002118_abnormal_lipid_homeostasis | 0.17990392 |
109 | MP0009780_abnormal_chondrocyte_physiolo | 0.17959870 |
110 | MP0003941_abnormal_skin_development | 0.17651544 |
111 | MP0003634_abnormal_glial_cell | 0.17494706 |
112 | MP0003045_fibrosis | 0.16883006 |
113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.16569069 |
114 | MP0005334_abnormal_fat_pad | 0.16452603 |
115 | MP0000579_abnormal_nail_morphology | 0.15002317 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 9.12624845 |
2 | Ventricular tachycardia (HP:0004756) | 7.54356574 |
3 | Atrial fibrillation (HP:0005110) | 6.77946348 |
4 | Primary atrial arrhythmia (HP:0001692) | 6.34157180 |
5 | Supraventricular tachycardia (HP:0004755) | 6.13699115 |
6 | Calf muscle hypertrophy (HP:0008981) | 6.06455967 |
7 | Supraventricular arrhythmia (HP:0005115) | 6.02752886 |
8 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.68468137 |
9 | Subaortic stenosis (HP:0001682) | 5.68468137 |
10 | * Lipoatrophy (HP:0100578) | 5.67768136 |
11 | Right ventricular cardiomyopathy (HP:0011663) | 5.52825324 |
12 | Muscle fiber splitting (HP:0003555) | 5.50744297 |
13 | Syncope (HP:0001279) | 5.43442481 |
14 | Abnormality of the calf musculature (HP:0001430) | 5.38829321 |
15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.38811636 |
16 | Exercise-induced muscle cramps (HP:0003710) | 5.35527833 |
17 | Exercise-induced myalgia (HP:0003738) | 5.01858036 |
18 | Prolonged QT interval (HP:0001657) | 4.82172083 |
19 | Bundle branch block (HP:0011710) | 4.81918273 |
20 | Palpitations (HP:0001962) | 4.78696870 |
21 | Hyporeflexia of lower limbs (HP:0002600) | 4.78327905 |
22 | * Dilated cardiomyopathy (HP:0001644) | 4.62574483 |
23 | Ventricular arrhythmia (HP:0004308) | 4.55150791 |
24 | Myoglobinuria (HP:0002913) | 4.36318512 |
25 | Asymmetric septal hypertrophy (HP:0001670) | 4.31174189 |
26 | Ventricular fibrillation (HP:0001663) | 4.27402376 |
27 | EMG: myopathic abnormalities (HP:0003458) | 4.05548342 |
28 | Heart block (HP:0012722) | 4.04921940 |
29 | Atrioventricular block (HP:0001678) | 4.04830451 |
30 | Abnormal atrioventricular conduction (HP:0005150) | 3.81755321 |
31 | Increased connective tissue (HP:0009025) | 3.64085053 |
32 | Abnormal EKG (HP:0003115) | 3.46848528 |
33 | Rhabdomyolysis (HP:0003201) | 3.28810832 |
34 | Left ventricular hypertrophy (HP:0001712) | 3.15584886 |
35 | Myotonia (HP:0002486) | 3.12028348 |
36 | Difficulty running (HP:0009046) | 2.91952923 |
37 | Hepatic necrosis (HP:0002605) | 2.86590142 |
38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.85760416 |
39 | Ragged-red muscle fibers (HP:0003200) | 2.82097870 |
40 | Acute necrotizing encephalopathy (HP:0006965) | 2.80788719 |
41 | * Palmoplantar keratoderma (HP:0000982) | 2.78779153 |
42 | Ketoacidosis (HP:0001993) | 2.70281871 |
43 | Bradycardia (HP:0001662) | 2.69901573 |
44 | Difficulty climbing stairs (HP:0003551) | 2.66627031 |
45 | Hypoglycemic coma (HP:0001325) | 2.60765935 |
46 | Hepatocellular necrosis (HP:0001404) | 2.47169640 |
47 | Rimmed vacuoles (HP:0003805) | 2.42393625 |
48 | Conjunctival hamartoma (HP:0100780) | 2.42031815 |
49 | Sudden cardiac death (HP:0001645) | 2.40724717 |
50 | Acute encephalopathy (HP:0006846) | 2.39649440 |
51 | Distal lower limb muscle weakness (HP:0009053) | 2.36783570 |
52 | Progressive macrocephaly (HP:0004481) | 2.31012557 |
53 | Testicular atrophy (HP:0000029) | 2.30969207 |
54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30788831 |
55 | Mitochondrial inheritance (HP:0001427) | 2.29171665 |
56 | Dicarboxylic aciduria (HP:0003215) | 2.28055627 |
57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28055627 |
58 | Hypoplastic heart (HP:0001961) | 2.27292452 |
59 | Limb-girdle muscle atrophy (HP:0003797) | 2.27035780 |
60 | Abnormality of the foot musculature (HP:0001436) | 2.25658180 |
61 | Cerebral edema (HP:0002181) | 2.23563630 |
62 | Increased muscle lipid content (HP:0009058) | 2.21872940 |
63 | Neck muscle weakness (HP:0000467) | 2.21086265 |
64 | Congestive heart failure (HP:0001635) | 2.18557649 |
65 | Increased CSF lactate (HP:0002490) | 2.18455359 |
66 | Pheochromocytoma (HP:0002666) | 2.16801279 |
67 | Increased variability in muscle fiber diameter (HP:0003557) | 2.14212604 |
68 | Double outlet right ventricle (HP:0001719) | 2.12452172 |
69 | Congenital malformation of the right heart (HP:0011723) | 2.12452172 |
70 | Resting tremor (HP:0002322) | 2.09798114 |
71 | Neoplasm of the adrenal gland (HP:0100631) | 2.09207403 |
72 | Areflexia of lower limbs (HP:0002522) | 2.08456269 |
73 | Abnormality of the endocardium (HP:0004306) | 2.08363883 |
74 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08056542 |
75 | Dysmetric saccades (HP:0000641) | 2.06390933 |
76 | Exercise intolerance (HP:0003546) | 2.00047716 |
77 | Hamartoma of the eye (HP:0010568) | 1.98790746 |
78 | Foot dorsiflexor weakness (HP:0009027) | 1.97010959 |
79 | Lactic acidosis (HP:0003128) | 1.96350223 |
80 | Respiratory failure (HP:0002878) | 1.96040523 |
81 | EMG: neuropathic changes (HP:0003445) | 1.94740435 |
82 | Steppage gait (HP:0003376) | 1.94677485 |
83 | Skin nodule (HP:0200036) | 1.94135809 |
84 | Muscle stiffness (HP:0003552) | 1.94093656 |
85 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93626167 |
86 | Type 1 muscle fiber predominance (HP:0003803) | 1.92549699 |
87 | Ketosis (HP:0001946) | 1.91875492 |
88 | Neuroendocrine neoplasm (HP:0100634) | 1.91610393 |
89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91587441 |
90 | Pulmonary artery stenosis (HP:0004415) | 1.91545059 |
91 | Lymphangioma (HP:0100764) | 1.91031474 |
92 | Large for gestational age (HP:0001520) | 1.90254819 |
93 | Frequent falls (HP:0002359) | 1.90203132 |
94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.88271570 |
95 | Distal lower limb amyotrophy (HP:0008944) | 1.87046642 |
96 | Abnormality of the tricuspid valve (HP:0001702) | 1.86807446 |
97 | Esophageal neoplasm (HP:0100751) | 1.86713031 |
98 | Neoplasm of head and neck (HP:0012288) | 1.86713031 |
99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85385461 |
100 | Hypoplastic left heart (HP:0004383) | 1.83744374 |
101 | Broad metatarsal (HP:0001783) | 1.82185187 |
102 | Hypoplastic ischia (HP:0003175) | 1.81511408 |
103 | Generalized muscle weakness (HP:0003324) | 1.80901528 |
104 | Scapular winging (HP:0003691) | 1.78549780 |
105 | Increased serum pyruvate (HP:0003542) | 1.77962282 |
106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75059883 |
107 | Abnormality of alanine metabolism (HP:0010916) | 1.75059883 |
108 | Hyperalaninemia (HP:0003348) | 1.75059883 |
109 | Periauricular skin pits (HP:0100277) | 1.73161749 |
110 | Preauricular pit (HP:0004467) | 1.73161749 |
111 | Patent foramen ovale (HP:0001655) | 1.72758629 |
112 | Muscular dystrophy (HP:0003560) | 1.72626824 |
113 | Nausea (HP:0002018) | 1.71776668 |
114 | Abnormality of glycolysis (HP:0004366) | 1.68604395 |
115 | Aneurysm (HP:0002617) | 1.68369722 |
116 | Transposition of the great arteries (HP:0001669) | 1.65021823 |
117 | Abnormal connection of the cardiac segments (HP:0011545) | 1.65021823 |
118 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.65021823 |
119 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.64729448 |
120 | Limb hypertonia (HP:0002509) | 1.64017787 |
121 | Skin pits (HP:0100276) | 1.63044828 |
122 | Progressive muscle weakness (HP:0003323) | 1.54071784 |
123 | Late onset (HP:0003584) | 1.52077658 |
124 | Abnormality of the salivary glands (HP:0010286) | 1.49051337 |
125 | Myokymia (HP:0002411) | 1.45359633 |
126 | Bulbar palsy (HP:0001283) | 1.42369309 |
127 | Toxemia of pregnancy (HP:0100603) | 1.41466385 |
128 | Central scotoma (HP:0000603) | 1.38817135 |
129 | Generalized aminoaciduria (HP:0002909) | 1.37605040 |
130 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.35593875 |
131 | Lower limb amyotrophy (HP:0007210) | 1.34497915 |
132 | Hip contracture (HP:0003273) | 1.30544959 |
133 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.27405848 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 5.39657442 |
2 | LMTK2 | 4.36989890 |
3 | MYLK | 4.36935427 |
4 | OBSCN | 4.01832195 |
5 | PHKG2 | 3.70104750 |
6 | PHKG1 | 3.70104750 |
7 | PKN2 | 3.64389111 |
8 | PDK4 | 3.35093443 |
9 | PDK3 | 3.35093443 |
10 | DMPK | 3.31159959 |
11 | TRIB3 | 2.79824913 |
12 | TIE1 | 2.44486668 |
13 | PIK3CA | 2.44413079 |
14 | STK24 | 2.35233063 |
15 | MUSK | 2.27659384 |
16 | BCKDK | 2.24262478 |
17 | NEK1 | 2.21972346 |
18 | PDK2 | 1.97880058 |
19 | PINK1 | 1.60681150 |
20 | PAK3 | 1.57909629 |
21 | GRK7 | 1.46027859 |
22 | MAP3K6 | 1.44235684 |
23 | CAMK2D | 1.42731201 |
24 | ILK | 1.42378103 |
25 | CDC42BPA | 1.39720224 |
26 | EPHA3 | 1.32969838 |
27 | STK4 | 1.20661868 |
28 | ROCK1 | 1.17887164 |
29 | WNK4 | 1.17548240 |
30 | ZAK | 1.14141008 |
31 | MARK1 | 1.10924994 |
32 | * PRKD1 | 1.07413275 |
33 | FLT3 | 1.04910590 |
34 | RIPK1 | 1.02731591 |
35 | DAPK3 | 1.02559293 |
36 | STK38L | 1.02310570 |
37 | MAP3K5 | 0.97667394 |
38 | INSRR | 0.95313067 |
39 | TRPM7 | 0.94003819 |
40 | MAPK12 | 0.90786439 |
41 | MAPKAPK3 | 0.87182978 |
42 | MAP3K7 | 0.86476324 |
43 | PRKAA1 | 0.84649114 |
44 | PDGFRA | 0.82074999 |
45 | CAMK4 | 0.81969842 |
46 | TAOK1 | 0.81241322 |
47 | PKN1 | 0.80934872 |
48 | KDR | 0.80543379 |
49 | MAPK4 | 0.80419102 |
50 | PRKAA2 | 0.80206430 |
51 | STK38 | 0.75414030 |
52 | LIMK1 | 0.75185273 |
53 | ROCK2 | 0.72688860 |
54 | ITK | 0.69709000 |
55 | PTK2B | 0.68740544 |
56 | WNK1 | 0.68120452 |
57 | RPS6KC1 | 0.66405729 |
58 | RPS6KL1 | 0.66405729 |
59 | TGFBR2 | 0.63991451 |
60 | CAMK1 | 0.61516784 |
61 | MAP3K3 | 0.61341224 |
62 | RPS6KA6 | 0.56828188 |
63 | EPHB1 | 0.55309474 |
64 | CAMK2B | 0.53929220 |
65 | PRKACB | 0.53839766 |
66 | MAP2K3 | 0.52148581 |
67 | STK39 | 0.50746027 |
68 | ICK | 0.50139780 |
69 | * CAMK2A | 0.46263907 |
70 | KSR2 | 0.43270207 |
71 | PTK6 | 0.40302873 |
72 | DDR2 | 0.39212000 |
73 | PDPK1 | 0.36953957 |
74 | * PRKACA | 0.36751581 |
75 | SIK1 | 0.36465613 |
76 | MAP2K1 | 0.33780770 |
77 | PRKCH | 0.33244753 |
78 | * PRKACG | 0.32969342 |
79 | PLK4 | 0.32212715 |
80 | PRKD3 | 0.32211694 |
81 | PDK1 | 0.32141211 |
82 | AKT2 | 0.29977319 |
83 | EPHB2 | 0.29652896 |
84 | PRKG2 | 0.28808235 |
85 | MAP3K10 | 0.27765526 |
86 | BLK | 0.27045823 |
87 | MARK2 | 0.26526033 |
88 | RPS6KA1 | 0.26473299 |
89 | CAMK2G | 0.26307945 |
90 | NEK9 | 0.25840999 |
91 | ZAP70 | 0.25490567 |
92 | MTOR | 0.25334134 |
93 | MAPK10 | 0.25152693 |
94 | SGK2 | 0.24533605 |
95 | RET | 0.24236946 |
96 | EEF2K | 0.23715039 |
97 | FER | 0.23078510 |
98 | LATS2 | 0.22829721 |
99 | STK11 | 0.22507392 |
100 | JAK1 | 0.20909307 |
101 | FGFR3 | 0.20408419 |
102 | LRRK2 | 0.19992696 |
103 | LATS1 | 0.19945400 |
104 | RAF1 | 0.19705158 |
105 | NLK | 0.18690982 |
106 | NME2 | 0.18062394 |
107 | AKT1 | 0.17996539 |
108 | TBK1 | 0.17963944 |
109 | PRKG1 | 0.17676424 |
110 | SGK3 | 0.17565577 |
111 | RPS6KA2 | 0.16492217 |
112 | * PRKCE | 0.16456161 |
113 | PRKD2 | 0.16346698 |
114 | UHMK1 | 0.16229540 |
115 | TGFBR1 | 0.14808811 |
116 | PDGFRB | 0.14191716 |
117 | RPS6KA3 | 0.12677657 |
118 | MAPK7 | 0.12120407 |
119 | MAPKAPK2 | 0.10944514 |
120 | FGFR4 | 0.10352284 |
121 | PRKCQ | 0.09515876 |
122 | SGK1 | 0.09007950 |
123 | PAK6 | 0.08942400 |
124 | MARK3 | 0.06604873 |
125 | JAK2 | 0.05218976 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.97816232 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.60204909 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.36997913 |
4 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.90325809 |
5 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.75214582 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.36832491 |
7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.14718964 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.07013796 |
9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.02960265 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.84550730 |
11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.52535154 |
12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.45583763 |
13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.28959514 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14106681 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.14036086 |
16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.08459278 |
17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.96719617 |
18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.94723827 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93533283 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73987480 |
21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45707244 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35754376 |
23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26291109 |
24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.23339460 |
25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14432406 |
26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08990027 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04476045 |
28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03888736 |
29 | Insulin resistance_Homo sapiens_hsa04931 | 1.03067962 |
30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96843037 |
31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92478268 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89828705 |
33 | Lysine degradation_Homo sapiens_hsa00310 | 0.88053535 |
34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81919145 |
35 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79680020 |
36 | Focal adhesion_Homo sapiens_hsa04510 | 0.78871498 |
37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77915189 |
38 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76934514 |
39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74430608 |
40 | Morphine addiction_Homo sapiens_hsa05032 | 0.73403291 |
41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73042947 |
42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69997188 |
43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69291746 |
44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68760300 |
45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66818805 |
46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61157805 |
47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60761933 |
48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59647417 |
49 | Tight junction_Homo sapiens_hsa04530 | 0.58725848 |
50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57511972 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56694200 |
52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53835316 |
53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52179770 |
54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52127766 |
55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51062370 |
56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49167566 |
57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49118518 |
58 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48844811 |
59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46736701 |
60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46629309 |
61 | Melanogenesis_Homo sapiens_hsa04916 | 0.46190815 |
62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45567154 |
63 | Renin secretion_Homo sapiens_hsa04924 | 0.43258699 |
64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43043674 |
65 | Adherens junction_Homo sapiens_hsa04520 | 0.41965548 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.40986196 |
67 | Prion diseases_Homo sapiens_hsa05020 | 0.40264731 |
68 | Amoebiasis_Homo sapiens_hsa05146 | 0.39976347 |
69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38861322 |
70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38399816 |
71 | Insulin secretion_Homo sapiens_hsa04911 | 0.37538320 |
72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37527831 |
73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35596374 |
74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35177574 |
75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33950494 |
76 | Salivary secretion_Homo sapiens_hsa04970 | 0.33929910 |
77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28737015 |
78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27038571 |
79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27038540 |
80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.25859472 |
81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25081461 |
82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23457469 |
83 | Mineral absorption_Homo sapiens_hsa04978 | 0.22315840 |
84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22307526 |
85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20423930 |
86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20263531 |
87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19865289 |
88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.19707606 |
89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19645086 |
90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19201334 |
91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.19091289 |
92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18838805 |
93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18613359 |
94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.18053357 |
95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17719179 |
96 | Platelet activation_Homo sapiens_hsa04611 | 0.16262411 |
97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16225733 |
98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14794475 |
99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14601567 |
100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13804514 |
101 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13746502 |
102 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.13223406 |
103 | Gap junction_Homo sapiens_hsa04540 | 0.12156715 |
104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12071765 |
105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.11830455 |
106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.11800350 |
107 | Taste transduction_Homo sapiens_hsa04742 | 0.11203445 |
108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09230862 |
109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09195574 |
110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.08918876 |
111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.08839320 |
112 | Bile secretion_Homo sapiens_hsa04976 | 0.08554097 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07545575 |
114 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07342423 |
115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.06616814 |
116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06614787 |
117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06581251 |
118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.03202837 |
119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.02367165 |
120 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0130971 |
121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0113730 |